There were 1,622 press releases posted in the last 24 hours and 413,570 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Personalized Stem Cells Announces Licensing Agreement for its Allogeneic Stem Cell Program Including COVID-19 Therapy

TO:
Michael Dale, President/COO
Personalized Stem Cells, Inc
+ +1 833-772-3557

FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image